+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gabapentin"

From
Gabapentin Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Gabapentin Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 144 Pages
  • Global
From
From
From
Visceral Pain Global Market Report 2024 - Product Thumbnail Image

Visceral Pain Global Market Report 2024

  • Report
  • April 2024
  • 175 Pages
  • Global
From
From
From
Trigeminal Neuralgia - Pipeline Insight, 2024 - Product Thumbnail Image

Trigeminal Neuralgia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

Gabapentin is a medication used to treat certain types of seizures and nerve pain. It is a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to produce its effects. It is used to treat epilepsy, neuropathic pain, hot flashes, and restless leg syndrome. It is also used off-label to treat anxiety and insomnia. Gabapentin is generally well-tolerated, but can cause side effects such as dizziness, drowsiness, and confusion. Gabapentin is available in both generic and brand-name forms. It is available in capsule, tablet, and oral solution forms. It is also available as an extended-release tablet, which is taken once daily. The market for Gabapentin is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the companies in the market include Pfizer, Mylan, Teva Pharmaceuticals, Sun Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more